clinical trials aiming to reduce the toxicity of novel agents in aml
Published 1 year ago • 198 plays • Length 6:41Download video MP4
Download video MP3
Similar videos
-
2:24
the latest clinical trials into novel aml therapies
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:14
promising novel agents in aml: menin inhibitors
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:34
cctx-001: a novel car-t therapy for aml
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
4:43
beat aml: a new clinical trial for acute myeloid leukemia patients
-
4:46
acute myeloid leukemia (aml) treatment options
-
24:36
mrd in aml: what is it and what do i do about it?
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
1:42
novel treatment combinations in aml: what’s to come?
-
1:24
exciting immunotherapy clinical trials for the management of aml
-
3:10
novel aml treament approaches
-
2:17
understanding the molecular complexity of aml
-
2:30
increasing aml clinical trial participation rates
-
2:11
clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (aml)
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
2:09
advances in the management of fit adults with aml
-
1:02
the impact of sequencing in aml
-
4:51
updates from the beat aml master trial
-
4:22
the role of mrd in aml